United Press International - April 9, 2003
Elizabeth Bryant, United Press International
The investigation was opened following charges filed in November, by a Tunisian couple whose son died 14 years ago, in the Mediterranean Tunisian city of Sousse. The death of 19-year-old Abdelkader Fradi was officially listed as due to a "cerebral hemorrhage." But the young hemophiliac had in fact contracted the AIDS virus, a taboo subject in Tunisia, his parents say.
According to French news reports, the Sousse hospital that cared for him used unheated blood products up to 1986, and possibly 1987, coming from the French firm Merieux.
"The parents want to know whether the blood contamination of their child was due to a non-preventable accident or to bad administration of the blood products," Francois Honnorat, the Paris-based lawyer for the Fradis, told United Press International Wednesday.
Honnorat said they first want to find out what happened before deciding whether to seek reparations.
The inquiry marks the first foray into whether a major French blood scandal may have caused illness and death overseas. More than 4,000 people were infected with the AIDS virus in France more than a decade ago, before tainted blood products were withdrawn. The scandal implicated major French politicians, leading doctors and Health Ministry officials.
In 1999, a special court acquitted former French Prime Minister Laurent Fabius, and the country's former social affairs minister. A former health minister, Edmond Herve, was convicted but not sentenced. In July, a French appeals court dismissed another trial implicating 30 people, sparking outrage.
Honnorat said many others in Tunisia and other developing countries may have been infected by the export of tainted blood products.
So far, however, no charges have been leveled for lack of sufficient evident, he said -- partly due to lack of transparency by health administrators in many poorer nations.
"We know very well Merieux marketed products that were not tested and not heated in a number of countries -- they recognized it in fact," the French lawyer said.
"The problem is the receivers never had sufficient proof to identify the products."
Difficulty gathering sufficient evidence also explained why the Fradi couple took so long to register their complaints in the Paris court, Honnorat added.
Merieux now goes by the name of Adventis-Pasteur. Contacted Wednesday at their headquarters in Lyon, France, company spokesmen did not immediately comment on the latest allegations.
030409
UP030403
Copyright © 2003 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .